Lakefront Biotherapeutics NV current report, Q1 FY2026

SEC Filing Summary: Form 6-K

Business Context and Reporting Period

This Form 6-K is filed by Galapagos NV (not Lakefront Biotherapeutics NV as indicated in metadata) for the month of March 2026. The filing, dated March 4, 2026, serves to incorporate by reference a press release issued on the same date (Exhibit 99.1). The registrant is a foreign private issuer based in Mechelen, Belgium, and files annual reports on Form 20-F.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document acts solely as a conduit for a press release and does not contain standalone financial statements or quantitative performance data.

Material Changes

The filing text does not provide a clear value regarding material changes versus the prior comparable period. The content is limited to the procedural incorporation of an external press release.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. These details are contained within the attached Exhibit 99.1 (Press Release), the text of which is not included in the provided input.

Key Facts for Investor Verification

  • Entity Discrepancy: The metadata lists "Lakefront Biotherapeutics NV," but the filing is explicitly for "Galapagos NV." Investors must verify the correct entity.
  • Content Source: All substantive information regarding the March 4, 2026 announcement is located in the attached Exhibit 99.1, which is not present in this text.
  • Financial Data Absence: No financial metrics are disclosed in this specific filing text; investors must refer to the press release or recent Form 20-F filings for financial status.
  • Regulatory Status: The company confirms it files annual reports on Form 20-F and has incorporated this report into multiple Form S-8 registration statements.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.